They explained that a reported death doesn’t mean that the death was definitely caused by the medicine, known as ...

Globally the demand for weight-loss drugs, specifically the glucagon-like peptide-1 (GLP-1) class of medications is ...

In one study, Khaled Alsabbagh Alchirazi, M.D., of Aurora Healthcare in Brookfield, Wisconsin, and colleagues found that ...

Researchers projected that more than 42,000 deaths could be averted annually, including more than 11,000 among those with type 2 diabetes.

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...

GLP-1 RAs can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight.

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The numbers are based on users or healthcare workers informing the regulator of adverse reactions to the drugs, known as ...

Susan McGowan, 58, from Lanarkshire, died after taking two low-dose injections of tirzepatide, known under the brand name ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by ...

Although chicken contains more protein than eggs, studies show that eggs have a higher digestibility value than chicken. Eggs ...

The use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for ...